Halloran Philip F, Madill-Thomsen Katelynn S, Böhmig Georg A, Myslak Marek, Gupta Gaurav, Kumar Dhiren, Viklicky Ondrej, Perkowska-Ptasinska Agnieszka, Famulski Konrad S
Alberta Transplant Applied Genomics Centre, Edmonton, AB, Canada.
Department of Medicine, Division of Nephrology and Transplant Immunology, University of Alberta, Edmonton, AB, Canada.
Transplantation. 2021 Nov 1;105(11):2374-2384. doi: 10.1097/TP.0000000000003884.
BK nephropathy (BKN) in kidney transplants diagnosed by histology is challenging because it involves damage from both virus activity and cognate T cell-mediated inflammation, directed against alloantigens (rejection) or viral antigens. The present study of indication biopsies from the Integrated Diagnostic System in the International Collaborative Microarray Study Extension study measured major capsid viral protein 2 (VP2) mRNA to assess virus activity and a T cell-mediated rejection (TCMR) classifier to assess cognate T cell-mediated inflammation.
Biopsies were assessed by local standard-of-care histology and by genome-wide microarrays and Molecular Microscope Diagnostic System (MMDx) algorithms to detect rejection and injury. In a subset of 102 biopsies (50 BKN and 52 BKN-negative biopsies with various abnormalities), we measured VP2 transcripts by real-time polymerase chain reaction.
BKN was diagnosed in 55 of 1679 biopsies; 30 had cognate T cell-mediated activity assessed by by MMDx and TCMR lesions, but only 3 of 30 were histologically diagnosed as TCMR. We developed a BKN probability classifier that predicted histologic BKN (area under the curve = 0.82). Virus activity (VP2 expression) was highly selective for BKN (area under the curve = 0.94) and correlated with acute injury, atrophy-fibrosis, macrophage activation, and the BKN classifier, but not with the TCMR classifier. BKN with molecular TCMR had more tubulitis and inflammation than BKN without molecular TCMR. In 5 BKN cases with second biopsies, VP2 mRNA decreased in second biopsies, whereas in 4 of 5 TCMR classifiers, scores increased. Genes and pathways associated with BKN and VP2 mRNA were similar, reflecting injury, inflammation, and macrophage activation but none was selective for BKN.
Risk-benefit decisions in BKN may be assisted by quantitative assessment of the 2 major pathologic processes, virus activity and cognate T cell-mediated inflammation.
通过组织学诊断肾移植中的BK肾病(BKN)具有挑战性,因为它涉及病毒活性和同源T细胞介导的炎症造成的损害,这些炎症针对同种异体抗原(排斥反应)或病毒抗原。国际协作微阵列研究扩展研究中综合诊断系统的指征活检的当前研究测量了主要衣壳病毒蛋白2(VP2)mRNA以评估病毒活性,并使用T细胞介导的排斥反应(TCMR)分类器评估同源T细胞介导的炎症。
通过局部标准护理组织学、全基因组微阵列和分子显微镜诊断系统(MMDx)算法对活检进行评估,以检测排斥反应和损伤。在102例活检的子集中(50例BKN和52例有各种异常的BKN阴性活检),我们通过实时聚合酶链反应测量VP2转录本。
在1679例活检中,55例被诊断为BKN;30例通过MMDx和TCMR病变评估具有同源T细胞介导的活性,但30例中只有3例在组织学上被诊断为TCMR。我们开发了一种BKN概率分类器,可预测组织学BKN(曲线下面积=0.82)。病毒活性(VP2表达)对BKN具有高度选择性(曲线下面积=0.94),并与急性损伤、萎缩纤维化、巨噬细胞活化和BKN分类器相关,但与TCMR分类器无关。具有分子TCMR的BKN比没有分子TCMR的BKN有更多的肾小管炎和炎症。在5例进行二次活检的BKN病例中,二次活检中VP2 mRNA下降,而在5例TCMR分类器中的4例中,评分增加。与BKN和VP2 mRNA相关的基因和通路相似,反映了损伤、炎症和巨噬细胞活化,但没有一个对BKN具有选择性。
对病毒活性和同源T细胞介导的炎症这两个主要病理过程进行定量评估,可能有助于BKN的风险效益决策。